Stopping cancer before it starts is the aim of a new prevention-first approach from the Dallas-based Cancer Prevention Initiative (CPI) and Lyda Hill Philanthropies, which committed a $750,000 matching challenge to accelerate the discovery and development of new medicines, such as vaccines and preventive drugs. …

The post Dallas’ Cancer Prevention Initiative Announces $750K Matching Grant Challenge From Lyda Hill Philanthropies appeared first on Dallas Innovates.

Existing treatments for leukemias and lymphomas can be effective. But for many people, they work only up to a point and may stop working altogether. That makes a new treatment option of paramount importance—and a research team at UT Southwestern in Dallas may have just found a big lead.…

The post UT Southwestern Researchers Target a Protein To Fight Leukemia, Lymphoma appeared first on Dallas Innovates.

“Delivery can be a fundamental, and oftentimes overlooked, part of a drug’s success.”

Karen Chen
Global Business Strategy Leader for Oncology
Celanese
.…on a new collaboration with Alessa Therapeutics.

Dallas-based Celanese Corporation has announced a collaboration with Alessa Therapeutics for developing a new oncology drug product, by utilizing the Celanese VitalDose EVA drug delivery platform.…

The post The Last Word: Celanese’s Karen Chen on Partnering with Alessa Therapeutics on Cancer Drug Delivery appeared first on Dallas Innovates.

Dallas’ Mark Cuban Cost Plus Drug Company announced a collaboration today with Houston-based OncoPower that will enable cancer patients using OncoPower to look up pricing and order less expensive medications.

The companies say they’ll build on OncoPower’s support for cancer patients by launching a Medication Savings Suite which will leverage Cost Plus Drugs’ competitive pricing on generic medication.…

The post Mark Cuban Cost Plus Drugs Partners with OncoPower to Help Cancer Patients Save on Medications appeared first on Dallas Innovates.

Aakha Biologics calls itself “a world-changing drug discovery engine.” In the last year, it’s seen a lot of changes itself. First its founder relocated from Boston to Dallas to start it up in May 2021, moving into interim space managed by BioLabs at UT Southwestern.…

The post Aakha Biologics Relocates from BioLabs Pegasus Park to Permanent North Texas HQ in Frisco appeared first on Dallas Innovates.